Clinical Trials Articles

While security of employment remains uncertain, it seems clinical trials professionals are becoming more interested in taking control of their own destiny—at least as it applies to their career.

As the use of biomarkers in clinical trials increases, the decision to use a biomarker in a trial needs to be taken in consideration with the cost and value they bring.

If only it were that easy. "I'd like data collection, the common technical document, patient reported outcomes, oh...and could you make sure that's all e?" And we all know e means electronic. And electronic is just another way of saying software, which should be just another way of saying easy, but easy e is not at first.

Reading an informed consent form as a potential clinical trial subject was a surreal experience for me. The research nurse at my dermatologist's office did not know my background—that I had spent the better part of the last 12 years designing clinical trials, writing protocols, and writing informed consent forms (ICF) like the one I held in my hands.

* Taking on the responsibility of business development for Image Metrix (Philadelphia, PA), including sales and marketing and client relations for existing clients and sponsors, Veronique Cardon has become the company's new director of client relations.

Jeffrey New

Embarking on a multimillion dollar project without first identifying and assessing the risks involved and then creating a risk–response strategy would be like sending a blindfolded person out into a foreign city with no seeing eye dog, no cane, and no prior training on what to expect.

Drug developers thrive on production speed. Speed that is continually accelerated by the threat to remain competitive, regardless of pressures from generics and pressures to deliver an increasingly complex product portfolio to satisfy global demand. It is no surprise that many pharmaceutical manufacturers are searching for new ways to keep pace.

1.) Preapproval Opportunities

http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/...

2.) Mission Possible: Rebranding Clinical Research

Electronic/paper/hybrid modes addressed in new product suite

TAKE updated PharmaReady suite

Since this past summer, the most common questions that I receive during my conference and meeting presentations revolve around the current recession and its impact on clinical research.